Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Background Episodes of depression are the most frequent cause of disability among patients with bipolar disorder. The effectiveness and safety of standard antidepressant agents for depressive episodes associated with bipolar disorder (bipolar depression) have not been well studied. Our study was designed to determine whether adjunctive antidepressant therapy reduces symptoms of bipolar depression without increasing the risk of mania. Methods In this double-blind, placebo-controlled study, we randomly assigned subjects with bipolar depression to receive up to 26 weeks of treatment with a mood stabilizer plus adjunctive antidepressant therapy or a mood stabilizer plus a matching placebo, under conditions generalizable to routine clinical care. A standardized clinical monitoring form adapted from the mood-disorder modules of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, was used at all follow-up visits. The primary outcome was the percentage of subjects in each treatment group meeting the criterion for a durable recovery (8 consecutive weeks of euthymia). Secondary effectiveness outcomes and rates of treatment-emergent affective switch (a switch to mania or hypomania early in the course of treatment) were also examined. Results Forty-two of the 179 subjects (23.5%) receiving a mood stabilizer plus adjunctive antidepressant therapy had a durable recovery, as did 51 of the 187 subjects (27.3%) receiving a mood stab…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on negative placebo‐controlled data, we do not recommend paroxetine (level 2 negative).245”
In the citing paper
“Antimanic medications reduce depressive symptoms in only one-third of patients (2).”
From Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial (2018) · cites this paper as [2]
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The mini international neuropsychiatric interview
Lecrubier, Y., Sheehan, D., Hergueta, T., & Weiller, E. (1998) · European Psychiatry · doi:10.1016/s0924-9338(99)80239-9 · Cited by 5,872
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Prevalence and Treatment of Mental Disorders, 1990 to 2003
Kessler, R. C., Demler, O., Frank, R. G., Olfson, M., Pincus, H. A., Walters, E. E., Wang, P., Wells, K. B., & Zaslavsky, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa043266 · Cited by 1,910
Extending Indications for Long-Term Pharmacotherapy: Opportunities and Challenges
Kane, J. M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.1 · Cited by 987
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationPerlis, R. H., Ostacher, M. J., Patel, J. K., Marangell, L. B., Zhang, H., Wisniewski, S. R., Ketter, T. A., Miklowitz, D. J., Otto, M. W., Gyulai, L., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.217 · Cited by 689
Self-citationPrevalence and Treatment of Mental Disorders
(2005) · New England Journal of Medicine · doi:10.1056/nejmc051936 · Cited by 650
Research works printed but not linked: 4
- Murray CJ, 1994, Bull World Health Organ, 72, 495
- Sheehan DV, 1998, J Clin Psychiatry, 59, 22
- Sachs GS, 1994, J Clin Psychiatry, 55, 391
- 10.1037/0021-843X.108.4.579 · doi:10.1037/0021-843x.108.4.579 · Paper page
Cited by
Items 501–600 of 935
Neglected but not negligible aspects of antidepressants and their availability in bipolar depression
Terao, T. (2021) · Brain and Behavior · doi:10.1002/brb3.2308 · Cited by 7
“The antidepressants used in that study (Sachs et al., 2007) were paroxetine (n = 93) or bupropion (n = 86), and neither paroxetine nor bupropion use was associated with an increased rate of treatment-emergent affective switches.”
BackgroundInfluentialFela-Thomas, A. L., Olotu, O. S., & Esan, O. (2018) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v24i0.1215 · Cited by 7
The Treatment of Bipolar Depression: Current Status and Future Perspectives
Jelen, L. A., & Young, A. H. (2020) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-020-00200-x · Cited by 7
Iosifescu, D. V. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15com09904 · Cited by 7
Miklowitz, D. J., & Johnson, S. L. (2017) · Wiley eBooks · doi:10.1002/9781394258949.ch8 · Cited by 10
Self-citationJin, K., Teng, Z., Li, J., Qiu, Y., Li, S., Xu, X., Wang, L., Chen, J., Huang, J., Xiang, H., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.164 · Cited by 6
Rodríguez, A., Williams, L. J., Lewis, S. C., Sinclair, P., Eldridge, S. M., Jackson, T., & Weir, C. J. (2025) · Clinical Trials · doi:10.1177/17407745251356423 · Cited by 8
Shimodera, S., Imai, Y., Kamimura, N., Morokuma, I., Fujita, H., Inoue, S., & Furukawa, T. A. (2012) · Asia-Pacific Psychiatry · doi:10.1111/j.1758-5872.2012.00218.x · Cited by 6
“Accumulating evidence now points to the differential therapeutics for bipolar and unipolar mood disorders (Sachs et al., 2007; Ghaemi et al., 2010).”
BackgroundLes antidépresseurs dans le trouble bipolaire
Courtet, P., Samalin, L., & Olié, É. (2011) · L Encéphale · doi:10.1016/s0013-7006(11)70053-7 · Cited by 8
Adherence to evidence-based treatment guidelines for bipolar depression in an inpatient setting
Freeland, K. N., Cogdill, B. R., Ross, C., Sullivan, C. O., Drayton, S. J., VandenBerg, A., Short, E. B., & Garrison, K. L. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/sp150023 · Cited by 6
“The use of these medications in the treatment of bipolar depression is plagued with controversy, mainly due to the lack of data or conclusive results.(13,14) Regardless, antiepileptics and antidepressants may be advantageous in patients with symptoms unresponsive to evidencebased treatments or in patients with concomi…”
Introduction to Psychiatry: Preclinical Foundations and Clinical Essentials
(2021) · Cambridge University Press eBooks · doi:10.1017/9780511846403 · Cited by 9
Suicidal behaviour in bipolar disorder: understanding the role of affective states
Saunders, K., & Hawton, K. E. (2014) · Bipolar Disorders · doi:10.1111/bdi.12267 · Cited by 6
Metabolic Side Effects of Risperidone in Children and Adolescents With Early-Onset Schizophrenia
Goëb, J.-L., Marco, S., Duhmael, A., Jardri, R., Kechid, G., Bordet, R., Delion, P., & Thomas, P. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0612h · Cited by 7
Management of Bipolar Depression
Chang, J. S., & Ha, K. (2011) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.85390 · Cited by 7
Treatment-emergent hypomania possibly associated with over-the-counter supplements
Olsufka, W., & Abraham, M.-A. A. (2017) · Mental Health Clinician · doi:10.9740/mhc.2017.07.160 · Cited by 6
“Also note that treatment-emergent affective switches are not instantaneous and may take weeks of treatment before an antidepressant-induced switch occurs.(16,20) The combination and possible synergistic effect of the OTC medications taken concomitantly may have increased the risk of a hypomanic episode.”
Ashton, M. M., Berk, M., Ng, C. H., Hopwood, M., Kavanagh, B. E., Williams, L. J., Sarris, J. J., & Dean, O. M. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025640 · Cited by 6
McGirr, A., Vöhringer, P. A., Ghaemi, S. N., Lam, R. W. M., & Yatham, L. N. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.19102 · Cited by 6
Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol
McGrath, B. M., Greenshaw, A. J., McKay, R. T., Slupsky, C. M., & Silverstone, P. H. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f03f09 · Cited by 6
“The evidence is mixed with respect to antidepressant efficacy in the treatment of bipolar depression [4,5].”
BackgroundPeng, D., Shen, T., Byrne, L. K., Zhang, C., Huang, Y., Yu, X., Zhao, J., McCabe, M. P., Mellor, D. J., & Fang, Y. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1487-3 · Cited by 6
Hankin, C. S., Koran, L. M., Bronstone, A. B., Black, D. W., Sheehan, D. V., Hollander, E., Dunn, J. D., Culpepper, L., Knispel, J., Dougherty, D. D., et al. (2009) · CNS Spectrums · doi:10.1017/s1092852900023956 · Cited by 7
Spanemberg, L., Massuda, R., Lovato, L. M., Paim, L. L., Vares, E. A., da Rocha, N. S., & Ceresér, K. M. M. (2011) · Psychiatric Quarterly · doi:10.1007/s11126-011-9191-1 · Cited by 7
“[8] However, the existing literature on bipolar depression is relatively smaller in comparison with that found on unipolar depression.”
ResultPharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression
Dubovsky, S. L. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.761206 · Cited by 6
“Whereas antidepressants treat and prevent recurrences of unipolar depression [4], these medications are not reliably effective for bipolar depression [5,6] and they may induce mania and mood cycling in bipolar disorder.”
BackgroundThe modern pharmacopoeia: a return to depressive realism?
Goldberg, J. F. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00632.x · Cited by 6
Polysomnographic Features of Medical and Psychiatric Disorders and Their Treatments
Plante, D. T., & Winkelman, J. W. (2009) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2009.04.008 · Cited by 6
Child and Adolescent Affective Disorders and their Treatment
Bowers, R. T., Weston, C. G., & Jackson, J. (2012) · Wiley eBooks · doi:10.1002/9781119962229.ch12 · Cited by 6
Clinical practice guidelines for the management of bipolar disorder: 2025 update
Menon, V., Ganesh, R., Deep, R., Sarkhel, S., Goswami, S., Mohapatra, D., Munoli, R. N., Sharma, P., Reddy, M., & Muralidharan, K. (2026) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry_1186_25 · Cited by 10
“[94] The following points may inform the clinical approach and considerations in using antidepressants in BD-I depression [20,162-165] : • Antidepressants should not be used as monotherapy in BD-I depression due to the risk of manic switch and lack of evidence for efficacy (as monotherapy).”
Spelber, D., Almeida, J., & Nemeroff, C. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00019-0 · Cited by 5
A Pilot Study of High-Frequency Transcranial Magnetic Stimulation for Bipolar Depression
Aaronson, S. T., Goldwaser, E. L., Croarkin, P. E., Geske, J. R., LeMahieu, A., Sklar, J., & Kung, S. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23m15056 · Cited by 5
Brancati, G. E., Torrigiani, S., Acierno, D., Fustini, C., Puglisi, F., Elefante, C., Lattanzi, L., Medda, P., & Perugi, G. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6098 · Cited by 5
“30 To the best of our knowledge, no study investigated on the impact of CSVD on ECT outcomes in patients with BD.”
InfluentialA preliminary open trial of nefazodone added to mood stabilizers for bipolar depression
Goldberg, J. F. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.037 · Cited by 5
“, 2006), although at least in the case of adjunctive paroxetine and bupropion, randomized data suggest no greater antidepressant efficacy than with mood stabilizers alone (Nemeroff et al., 2001; Sachs et al., 2007).”
BackgroundResultDubovsky, S. L., & Warren, C. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s16078 · Cited by 5
“Neuropsychiatric Disease and Treatment 2013:9 Depression is the most common complaint of patients with bipolar mood disorders, and many of these patients are treated with antidepressants, which have not been found to be more effective than placebo for bipolar depression.(22,23) Although the issue has been debated, ant…”
Awareness changes placebo effects for feeling relaxed, but not for liking
Kuenzel, J., Blanchette, I., Zandstra, E. H., Thomas, A. K., & El‐Deredy, W. (2011) · Journal of Marketing Communications · doi:10.1080/13527266.2010.548009 · Cited by 6
“Placebo studies were predominately conducted in the fields of medical drugs such as antidepressants (for a recent study see Sachs et al. 2007), pain medication (e.g. Watson et al. 2007 or Morton et al. 2010), and, in the food domain, for stimulants such as caffeine (for example, Kirsch and Weixel…”
BackgroundEffects of Antidepressant Use and Anxiety on Psychiatric Rehospitalization in Bipolar Depression
Vardi, K., Warner, J. L., & Philip, N. S. (2014) · Annals of Clinical Psychiatry · doi:10.1177/104012371402600308 · Cited by 5
Hussain, S. A., Abbas, A. N., Alhadad, H. A., Al‐Jumaili, A. A., & Abdulrahman, Z. S. (2017) · Pharmacy Practice · doi:10.18549/pharmpract.2017.03.979 · Cited by 5
“Moreover, reporting the specific diagnosis for each drug prescribed is likely to be of high value and feasible, and at the same time could reduce prescribing errors.(17) In the present study, the agreement rate is far less than that reported by other studies elsewhere(18,19) that cover shorter duration (less than 2 ye…”
ResultPsychopharmacology and Experimental Therapeutics for Bipolar Depression
Jha, M. K., & Murrough, J. W. (2019) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20190009 · Cited by 6
Tomioka, H., Masuda, J., Takada, A., & Iwanami, A. (2020) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2020.136012 · Cited by 5
“As to affective switches antidepressants are not more likely to cause treatment-emergent affective switches than placebo [19].”
BackgroundMaiti, R., Mishra, A., Mishra, B. R., & Jena, M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06019-y · Cited by 6
Dilemma for enhancing psychiatrists’ adherence to guideline (evidence)-based practice
Han, C., Wang, S., Lee, S. J., Patkar, A. A., Masand, P. S., & Pae, C. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.811196 · Cited by 5
Berry, R. B. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0326-9.00029-4 · Cited by 8
Unmet Needs in Psychiatry: Bipolar Depression
Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2020) · Springer eBooks · doi:10.1007/978-3-030-42637-8_4 · Cited by 8
Chapter 49. Treatment of Bipolar Disorder
Strakowski, S. M., & Keck, P. E. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as49 · Cited by 5
Treatment of Bipolar Depression
Post, R. M., Baldassano, C. F., Perlis, R. H., & Ginsberg, D. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-435-7_5 · Cited by 5
Baldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_3 · Cited by 9
Mood lability and bipolar disorder in children and adolescents
Miller, L., & Barnett, S. R. (2008) · International Review of Psychiatry · doi:10.1080/09540260801889088 · Cited by 5
“However, recent evidence suggests that adjunctive antidepressant treatment for bipolar depression may not increase efficacy over treatment with a mood stabilizer alone (Sachs et al., 2007).”
BackgroundPsychopharmacological treatment of bipolar disorder in Latin American
Heeren, O., de Carmona, M. S., Vásquez, G., Córdoba, R., Forero, J., Madrid, L., Lara, D. R., Medina, R., & Meza, L. (2011) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2011.08.001 · Cited by 7
Psychopharmacology in Primary Care Settings
Benich, J. J., Bragg, S. W., & Freedy, J. R. (2016) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2016.01.002 · Cited by 6
Nassan, M. M., Jia, Y., Jenkins, G. D., Colby, C. L., Feeder, S. E., Choi, D., Veldić, M., McElroy, S. L., Bond, D. J., Weinshilboum, R. M., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.005 · Cited by 5
Mousavi, Z., Johnson, S. L., & Li, D. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.097 · Cited by 5
Behavior Therapy and Cognitive‐Behavioral Therapy
Craighead, W. E., Craighead, L. W., Ritschel, L. A., & Zagoloff, A. D. (2012) · Wiley eBooks · doi:10.1002/9781118133880.hop208012 · Cited by 7
Gao, K., Kemp, D. E., Wu, R., & Calabrese, J. R. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch105 · Cited by 7
Self-citationProgress and trends of research on mineral elements for depression
Gao, B., Li, C., Qu, Y., Cai, M., Zhou, Q., Zhang, Y., Lu, H., Tang, Y., Li, H., & Shen, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35469 · Cited by 7
Aydın, İ. H., & El‐Mallakh, R. S. (2024) · Bipolar Disorders · doi:10.1111/bdi.13494 · Cited by 5
“35,36 Concern regarding the use of antidepressants in bipolar depression is reflected in expert opinion 37 but not in clinical treatment.”
Psychosocial Approaches to the Treatment of Bipolar Disorder
Miklowitz, D. J., & Gitlin, M. J. (2015) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.130106 · Cited by 5
Self-citationPharmacological Treatment of Refractory Bipolar Disorder: What Does the Evidence Say?
Fountoulakis, K. Ν. (2013) · Journal of Depression & Anxiety · doi:10.4172/2167-1044.1000127 · Cited by 4
“The problem is that the above studies are not placebo-controlled, and unfortunately, a recent double-blind, placebo-controlled study, of adding an antidepressant on a mood stabilizer in 179 bipolar depressed patients was negative [71].”
ResultAn Overview of Machine Learning Applications in Mood Disorders
Topolski, N., Jeong, S. H., & Mwangi, B. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.017 · Cited by 4
Scott, J. L., Bentall, R. P., Kinderman, P., & Morriss, R. K. (2022) · International Journal of Bipolar Disorders · doi:10.1186/s40345-022-00259-3 · Cited by 4
“This incorporated two multi-site RCTs that examined the effects of different medication regimes and different psychological therapies on acutely depression in individuals diagnosed with BD I and II (Sachs et al. 2007; Miklowitz et al. 2007).”
BackgroundBrown, T. E. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511780752.011 · Cited by 8
Predicting Participation in Psychiatric Randomized Controlled Trials: Insights From the STEP-BD
Busch, A. B., He, Y., Zelevinsky, K., & O’Malley, A. J. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201300557 · Cited by 4
“Persons enrolled in at least one of two STEP-BDRCTs for the treatment of acute bipolar depression (the adjunctive antidepressant RCT or the psychosocial treatment RCT) (16,17) were compared with those in the observational armwho did not participate in either of these RCTs.”
Zonisamide for Bipolar Depression: A Randomized, Double Blind, Placebo-Controlled, Adjunctive Trial
Dauphinais, D., Knable, M. B., Rosenthal, J., Polanski, M., & Rosenthal, N. E. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4065 · Cited by 4
Caldieraro, M. A., Walsh, S. L., Deckersbach, T., Bobo, W. V., Gao, K., Ketter, T. A., Shelton, R. C., Reilly-Harrington, N. A., Tohen, M. F., Calabrese, J. R., et al. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417741982 · Cited by 4
Self-citationПотанин, С. С., & Ma, M. (2020) · Psikhiatriya · doi:10.30629/2618-6667-2020-18-2-51-60 · Cited by 4
Fernandes, T. B., do Carmo, L. R., Araújo, M., Moreira, S. A., & Macêdo, J. P. (2023) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2023v5n5p173-187 · Cited by 13
Disability and Overall Burden Related with Bipolar Disorder
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_12 · Cited by 4
Akut- und Langzeittherapie der bipolaren Depressionen
Grunze, H., & Dargel, S. (2010) · Der Nervenarzt · doi:10.1007/s00115-009-2851-9 · Cited by 5
Bipolar spektrumunun yeniden keşfi
Altınbaş, K., Smıth, D. J., & Craddock, N. J. (2011) · Nöro Psikiyatri Arşivi · doi:10.4274/npa.y5818 · Cited by 5
“There is currently considerable uncertainty about the long-term usefulness of antidepressants for bipolar-type depressions, as highlighted by the finding of a lack of benefit of antidepressants added to mood stabilizers within the STEP-BD trial (11).”
BackgroundFAWCETT, J. A. (2008) · Psychiatric Annals · doi:10.3928/00485713-20080701-02 · Cited by 4
Tundo, A., Calabrese, J. R., Proietti, L., & de Fillippis, R. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.036 · Cited by 4
“…Treatments section, we prescribed TCA and SNRI, considered to be at high risk of inducing switch (Pacchiarotti et al, 2013), only after more modern ADs had been tried and co-treated all patients with one or more mood stabilizer(s) to minimize switch rates (Henry et al., 2001; Sachs et al., 2007).”
BackgroundMethodSelf-citationBorderline Personality Disorder Is Not a Subtype of Bipolar Disorder
Eftekhar, M., & Shabani, A. (2009) · Iranian Journal of Psychiatry and Clinical Psychology · Cited by 4
Bipolar depression: Managing patients with second generation antipsychotics
Avery, L. M., & Drayton, S. J. (2016) · The International Journal of Psychiatry in Medicine · doi:10.1177/0091217416636576 · Cited by 4
“One of the largest national studies of treatment for bipolar depression (STEP-BD) reported similar placebo and antidepressant response rates in patients concurrently receiving lithium, valproate, carbamazepine, or a second generation antipsychotic.(6) In addition, the results from a meta-analysis that combined data fr…”
ResultA Descriptive Analysis of Factors Leading to a 1-Year Remission in Bipolar Disorder
RAPPORT, D. J., Kaplish, D., McGrady, A. V., McGinnis, R. A., Whearty, K., Thomas, M., & Fine, T. H. (2015) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000102 · Cited by 4
Self-citationThe Need for Quality Improvement in Behavioral Health
Gaudiano, B. A., Dalrymple, K. L., D’Avanzato, C., & Bunaciu, L. (2016) · Springer eBooks · doi:10.1007/978-3-319-26209-3_3 · Cited by 5
Mood stabilisers in the treatment of Bipolar II Disorder
Hadjipavlou, G. A., & Yatham, L. N. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.011 · Cited by 4
Rothberg, B., & Schneck, C. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1160-8.10047-8 · Cited by 4
Determining Patient Candidacy for Antidepressant Use in Bipolar Disorder
Goldberg, J. F. (2019) · Psychiatric Annals · doi:10.3928/00485713-20190807-03 · Cited by 6
Bipolarity in Women: Therapeutic Issues
McElroy, S. L., Arnold, L. M., & Altshuler, L. L. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch16 · Cited by 4
Antidepressant Treatment and Smoking Cessation in Bipolar Disorder
Dervaux, A. (2009) · JAMA · doi:10.1001/jama.2009.705 · Cited by 4
Upping the ante on antidepressants
Malhi, G. S. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00645.x · Cited by 4
“Based on the evidence of clinical trials such as STEP-BD (12), Dr. Ghaemi argues that despite their widespread use in clinical practice, antidepressants are essentially ineffective in the management of bipolar depression, both in acute and maintenance phases of treatment.”
BackgroundMethodInfluentialAntidepressant Prescribing and Rapid Cycling
Goldberg, J. F. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08030346 · Cited by 4
Efficacy and safety of bright light therapy for bipolar depression.
Juruena, M. F., Young, A. H., Hodsoll, J., Lewis, G., & Veale, D. (2020) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13005 · Cited by 3
Bipolar disorder: The foundational role of mood stabilizers
Shah, B. (2023) · Current Psychiatry · doi:10.12788/cp.0346 · Cited by 5
Pharmacological treatment of bipolar depression
Young, A. H., & Nemeroff, C. B. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776922.004 · Cited by 3
Tamayo, J. M. (2011) · Actas Españolas de Psiquiatría · Cited by 5
Haarman, B. C. M., der Lek, R. F. R., Ruhé, H. G., de Groot, J. C., Nolen, W. A., & Doorduin, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_9 · Cited by 3
Mood Disorders: Brain Imaging and Therapeutic Implications
(2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018 · Cited by 3
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_16 · Cited by 3
Shafiee, A., Moltazemi, H., Amini, M. J., Gargari, O. K., Safari, F., Abhari, F. S., Jafarabady, K., & Bakhtiyari, M. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103839 · Cited by 5
A Case of Pancreatitis Associated With Aripiprazole in the Absence of Hyperglycemia
Kiraly, B., & Gunning, K. M. (2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0612e · Cited by 3
Ittasakul, P., Johnson, K. R., Srivastava, S., Childers, M. E., Brooks, J. O., Hoblyn, J. C., & Ketter, T. A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.024 · Cited by 3
“Effectiveness studies attempt to bridge this gap, involving more clinical heterogeneity, complex treatment regimens, and relevant outcomes such as recovery (Nierenberg et al., 2006; Sachs et al., 2007) or all-cause discontinuation (Lieberman et al.”
BackgroundSelf-citationOkunji, P. O., Ezebuihe, I., & Okunji, C. (2020) · Family Medicine and Primary Care Open Access · doi:10.29011/2688-7460.100041 · Cited by 3
Shvartzman, Y., Krivoy, A., Valevski, A., Gur, S., Weizman, A., & Hochman, E. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.01.010 · Cited by 3
Heyman-Kantor, R., Rizk, M., Sublette, M. E., Rubin‐Falcone, H., Yousefzadeh-fard, Y., Burke, A. K., Oquendo, M. A., Sullivan, G. M., Milak, M. S., Zanderigo, F., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.10.071 · Cited by 3
Murata, S., Murphy, M. L. M., Khanna, R., Hoppensteadt, D., Fareed, J., & Halaris, A. E. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100117 · Cited by 3
Evidence Based Combination Therapy for Bipolar Disorder
Magiria, S., Siamouli, M., Gonda, X., Iacovides, A., & Fountoulakis, K. Ν. (2012) · Springer eBooks · doi:10.1007/978-94-007-5799-8_9 · Cited by 3
Kang, S. H., Kim, Y., An, H., Joo, Y. H., & Kim, C. Y. (2008) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500802585772 · Cited by 3
“not associated with increased efficacy compared with mood stabilizers [11].”
BackgroundInterpersonal psychotherapy: recent indications beyond major depression
Bellino, S., Rinaldi, C., Brunetti, C., Bogetto, F., & Psichiatrica, C. (2012) · Institutional Research Information System University of Turin (University of Turin) · Cited by 4
Les antidépresseurs ont-ils encore un intérêt dans la dépression bipolaire ?
Bulteau, S., Doligez, N., Victorri‐Vigneau, C., Laforgue, E., Guitteny, M. A., Sauvaget, A., & Vanelle, J. (2016) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2015.12.010 · Cited by 5
Review of Transcranial Magnetic Stimulation for Bipolar Disorder
Gilmer, W. S., & Zarnicki, J. N. (2012) · Psychopharm Review · doi:10.1097/01.psyphr.0000413086.80585.ce · Cited by 3
Recent advances in bipolar disorder pharmacotherapy: focus on bipolar depression and rapid cycling
Datta, V., & Cleare, A. J. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.10 · Cited by 3
Polypharmazie in der Behandlung bipolarer Störungen
Grunze, H., Forsthoff, A., & Born, C. (2006) · Springer eBooks · doi:10.1007/3-211-31221-8_3 · Cited by 4
da Silva, C. A. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-01102012-162421 · Cited by 7
Metadata
- Authors
- Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., Ketter, T. A., Patel, J., Hauser, P., Rapport, D., Martinez, J. M., Allen, M. H., Miklowitz, D. J., Otto, M. W., Dennehy, E. B., & Thase, M. E.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- University Hospitals Cleveland Medical Center (US)
- Baylor College of Medicine (US)
- University of Pittsburgh (US)
- University of Pennsylvania (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Oklahoma (US)
- Stanford Medicine (US)
- University of Massachusetts Chan Medical School (US)
- University of Toledo (US)
- University of Colorado Boulder (US)
- Boston University (US)
- Purdue University West Lafayette (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-26
- Volume
- 356
- Issue
- 17
- Pages
- 1711-1722
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2166423384
- Semantic Scholar
- c224a40d0ffd6471e7b72b38060d169ba1cdec34
- Cited by
- 937
- References
- 27
- Citations by year
- 2026: 16 · 2025: 16 · 2024: 33 · 2023: 17 · 2022: 15 · 2021: 68 · 2020: 33 · 2019: 29 · 2018: 36 · 2017: 28 · 2016: 53 · 2015: 47 · 2014: 51 · 2013: 52 · 2012: 61
- FWCI
- 56.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01mh80001-12-0-0)
- National Institute of Mental Health (N01-MH80001)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- bipolar depression, adjunctive antidepressant therapy, mood stabilizers, euthymia, bipolar disorder, antidepressant safety
- MeSH terms
- Adult, Bipolar Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Bupropion, Treatment Outcome, Paroxetine, Antidepressive Agents, Second-Generation, Antimanic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.